Table 3. Thyroid cancer risk according to dose before age 15 years and to work at nuclear sites.
Total population (229 cases and 373 controls)
|
Excluding unifocal micro-carcinomas, cancers of unknown size and their controls (141 cases/231 controls)
|
|||||
---|---|---|---|---|---|---|
Exposure | Cases/controls | OR (95% CI)a | P-value for trend | Cases/controls | OR (95% CI)a | P-value for trend |
Thyroid dose before age 15 years | ||||||
<1 mGy | 156/250 | 1b | 93/149 | 1b | ||
1–9.9 mGy | 61/111 | 1.0 (0.5–1.9) | 0.04 | 39/74 | 1.1 (0.5–2.6) | 0.02 |
10–19.9 mGy | 7/9 | 3.3 (0.8–14) | 5/6 | 6.2 (0.9–41) | ||
20–39 mGy | 5/3 | 5.7 (0.8–45) | 4/2 | 11.6 (1.0–132) | ||
Work at nuclear sites during tests | ||||||
No | 219/361 | 1b | 132/222 | 1b | ||
Yes | 10/12 | 1.0 (0.3–3.5) | 0.9 | 9/9 | 1.5 (0.4–5.8) | 0.7 |
Abbreviations: OR=odds ratio, CI=confidence interval.
Adjusted on ethnic group, level of education, body surface area, family history of thyroid cancer and number of pregnancies for women.
Reference category.